Orexigen Therapeutics (OREX) Gains on Korean Pact

Orexigen Therapeutics, Inc. OREX shares climbed 11.5% to $4.26. Orexigen Therapeutics reported a Korean distributorship agreement with Kwang Dong Pharmaceutical Company and reported a Q2 loss of $22.5 million on revenue of $5.2 million. Share volume was 5.7 million, dwarfing an all-day average of 2.6 million